To address this, we explored mRNA of lung cancer patients from The Cancer Genome Atlas (TCGA) where we found that RASSF1A expression positively correlates with a good prognosis and overall survival in lung adenocarcinoma patients but not in squamous cell carcinomas (Fig 1A). The gene discussed is RASSF1; the disease is squamous cell carcinoma.